PT  - JOURNAL ARTICLE
AU  - Ferris, Daron G.
AU  - Waller, Jennifer L.
AU  - Owen, Ashley
AU  - Smith, Jozette
TI  - HPV Vaccine Acceptance Among Mid-Adult Women
AID  - 10.3122/jabfm.2008.01.070103
DP  - 2008 Jan 01
TA  - The Journal of the American Board of Family Medicine
PG  - 31--37
VI  - 21
IP  - 1
4099  - http://www.jabfm.org/content/21/1/31.short
4100  - http://www.jabfm.org/content/21/1/31.full
SO  - J Am Board Fam Med2008 Jan 01; 21
AB  - Objective: To determine correlates of human papillomavirus (HPV) vaccine acceptance in mid-adult women.Methods: A convenience sample of 472 mid-adult women completed a 2-part, 69-item survey that included demographic, knowledge, and behavioral variables as potential correlates of vaccine acceptance. Univariable and multivariable logistic regression models were used to identify correlates for vaccine acceptance.Results: Mid-adult women who received the HPV vaccine were more likely to be younger than 55 years (P < .001); have had an abnormal Papanicolaou test (odds ratio [OR], 2.15; 95% CI, 1.18–3.92); understand that HPV causes cervical cancer (OR, 2.39; 95% CI, 1.08–5.30); feel at risk for HPV infection (OR, 2.14; 95% CI, 1.00–4.57), and feel it is important for their partner (OR, 25.20; 95% CI, 9.66–65.72) and children (OR, 3.54; CI, 0.51–24.56) to get the HPV vaccine. Monogamous mid-adult women (OR, 0.46; 95% CI, 0.21–1.00); women who did not want any vaccines (OR, 0.26; 95% CI, 0.07–0.92); and women who felt it was too late to get the vaccine (OR, 0.18; 95% CI, 0.08–0.44) were less likely to want the HPV vaccine.Conclusions: These clinical predictors of HPV vaccine acceptance will help clinicians recognize mid-adult women who may be more receptive to vaccination.